Physician profile
Herman Dick
NPI 1891891370
$1,946.80
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $337 · 2021: $748 · 2022: $194.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $401.89 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $158.87 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $145.29 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $115.10 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $113.28 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $105.23 | 2022 | |
| Jazz Pharmaceuticals INC. | $104.43 | 2020-2022 | |
| Emd Serono, INC. | $102.79 | 2019-2021 | |
| Biogen, INC. | $94.07 | 2019 | |
| Grifols USA, LLC | $88.74 | 2019 | |
| Mallinckrodt Hospital Products INC. | $79.15 | 2020-2021 | |
| Abbvie INC. | $72.90 | 2021-2022 | |
| Genzyme Corporation | $64.13 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $44.86 | 2020-2021 | |
| Genentech USA, INC. | $33.41 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $33.00 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $32.00 | 2019-2020 | |
| Amgen INC. | $27.29 | 2019 | |
| Sk Life Science, INC. | $20.94 | 2021 | |
| Csl Behring | $19.92 | 2021 | |
| Impel Pharmaceuticals INC. | $18.70 | 2022 | |
| Celgene Corporation | $18.11 | 2021 | |
| Kyowa Kirin, INC. | $15.59 | 2022 | |
| Amneal Pharmaceuticals LLC | $14.29 | 2019 | |
| Ucb, INC. | $11.64 | 2020 | |
| Acadia Pharmaceuticals INC | $11.18 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herman Dick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.